24/7 Patient Assistance: 760-405-8205

Houman M. Fekrazad,

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. M. Houman Fekrazad is a specialist in medical oncology in Lancaster, California and he is working in collaboration with many regional hospitals, like Antelope Valley Hospital and City of Hope. He got his medical diploma from Shiraz University of Medical Sciences. He did two residency programs in internal medicine. The first one was done at University of Alabama Medical Center and the second one at Caraway Methodist Medical Center. He also did a fellowship in hematology/oncology at the University of New Mexico. The doctor is board certified in hematology, internal medicine, and medical oncology and he has a practical experience of more than 20 years.

  • Education & Training


    Shiraz University of Medical Sciences

    Medical School


    Caraway Methodist Medical Center



    University of Alabama Medical Center



    University of New Mexico


  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Antelope Valley Hospital

    Languages: English/Spanish

    (661) 949-5000

    1600 W Avenue J

    Lancaster, California 93534

    Read More

    City of Hope Duarte - Comprehensive Cancer Center

    Languages: English/Spanish

    (800) 826-4673

    1500 East Duarte Road

    Duarte, California 91010

    Read More
  • Publications & Memberships

    Dr. Houman M. Fekrazad has contributed to 3 publications.

    Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups.

    Libby, E.,Garcia, D.,Quintana, D.,Fekrazad, M. H.,Bauman, J.,Ebaid, A.,Hromas, R.,Rabinowitz, I.,Wiggins, C.; Leuk. Lymphoma. 2014 Mar 05.

    See more >>

    Spontaneous regression of high grade primary gastric Lymphoma in an untreated viral hepatitis infection.

    Rojas-Hernandez, C. M.,Coleman, J. F.,Czuchlewski, D. R.,Fekrazad, M. H.; Leuk. Lymphoma. 2014 Feb 12.

    See more >>

    A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma.

    Bauman, J. E.,Arias-Pulido, H.,Lee, S. J.,Fekrazad, M. H.,Ozawa, H.,Fertig, E.,Howard, J.,Bishop, J.,Wang, H.,Olson, G. T.,Spafford, M. J.,Jones, D. V.,Chung, C. H.; Oral Oncol. 2013 May.

    See more >>